论文部分内容阅读
报告非选择性内皮素 a/ b(ETa/ b)受体拮抗剂改善充血性心衰 (CHF)病人的血动力学。因 ETb受体介导一氧化氮的释放和清除 ET- 1,因此 ,选择性 ETa拮抗剂是非常有益的。作者研究了选择 ETa受体拮抗剂对 CHF病人的血动力学和神经体液作用。本研究为前瞻性多中心研究。入选 95例 C
Non-selective endothelin a / b (ETa / b) receptor antagonists are reported to improve hemodynamics in patients with congestive heart failure (CHF). Because ETb receptors mediate the release of nitric oxide and eliminate ET-1, selective ETa antagonists are very beneficial. The authors studied the hemodynamic and neurohumoral effects of the selection of ETa receptor antagonists on CHF patients. This study is a prospective, multicenter study. Selected 95 cases of C